IMMUTEP LIMITED — Director's Dealing 2013

Apr 10, 2013

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: PRIMA BIOMED LIMITED (ASX:PRR) ACN:[90 009 237 889 ]

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Mr Matthew Lehman Date of Last Notice: 24 May 2012

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Direct	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest.		N/A
Date of change		11 April 2013
No. of securities held prior to change		1) Ordinary Fully Paid Shares		Options1,700,000-1,700,000
			Shares	Options
		Direct	1,100,000	1,700,000
		Indirect	-	-
		**Total **	1,100,000	1,700,000
Class		2) American	Depositary Recei	pts (ADR) traded onaid shares
		the NAS	DAQ
		1 ADR =	30 ordinary fully	aid shares

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number acquired		2) American	Depositary Receipts (ADR)SharesOptions2,000---2,000-	Depositary Receipts (ADR)SharesOptions2,000---2,000-	Depositary Receipts (ADR)SharesOptions2,000---2,000-
			Shares		Options
		Direct	2,000		-
		Indirect	-		-
		Total	2,000		-
Number disposed					Options---
			Shares		Options
		Direct	-		-
		Indirect	-		-
		Total	-		-
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation		US$ 6,279.81
No. of securities held after change		1) Ordinary Fully Paid SharesSharesOptionsDirect1,100,0001,700,000Indirect--Total1,100,0001,700,0002) American Depositary Receipts (ADR)SharesOptionsDirect2,000-Indirect--Total2,000-
			Shares	Options
		Direct	2,000	-
		Indirect	-	-
		Total	2,000	-
Nature of changeExample: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestmentplan, participation in buy-back		Acquiring 2,000 ADR’s at US$3.14 each that aretraded on the NASDAQ

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

disclosed in this part.
Detail of contract	N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation
Interest after change

Part 3 - +Closed Period

Were the interests in the securities or contracts detailed above traded No during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided on what date was this provided?

11.04.2013

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002